We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
121 hedge funds and large institutions have $392M invested in Esperion Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
65% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 31
14% more call options, than puts
Call options by funds: $13.8M | Put options by funds: $12.1M
20% less funds holding
Funds holding: 151 → 121 (-30)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
54% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 54
72% less capital invested
Capital invested by funds: $1.38B → $392M (-$991M)
Holders
121
Holders Change
-30
Holders Change %
-19.87%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
25
Increased
51
Reduced
31
Closed
54
Calls
$13.8M
Puts
$12.1M
Net Calls
+$1.7M
Net Calls Change
-$75.6M
Top Buyers
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$114M |
| 2 |
VAM
Visium Asset Management
New York
|
-$64.7M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$51.1M |
| 4 |
Two Sigma Investments
New York
|
-$22.4M |
| 5 |
SAM
Senzar Asset Management
New York
|
-$12.6M |
